A genome-wide association scan in individuals with Crohn's disease by the Wellcome Trust Case Control Consortium detected strong association at four novel loci. We tested 37 SNPs from these and other loci for association in an independent case-control sample. We obtained replication for the autophagy-inducing IRGM gene on chromosome 5q33.1 (replication P = 6.6 Â 10 -4 , combined P = 2.1 Â 10 -10 ) and for nine other loci, including NKX2-3, PTPN2 and gene deserts on chromosomes 1q and 5p13.
Crohn's disease is a common form of chronic inflammatory bowel disease. Established susceptibility genes NOD2 (CARD15), IL23R and ATG16L1 (refs. [1] [2] [3] [4] showed strong evidence of association in the Wellcome Trust Case Control Consortium (WTCCC, see Supplementary Note online) genome-wide scan of 1,748 Crohn's disease cases and 2,938 controls genotyped using the Affymetrix 500K chip 5 . Six other loci also showed highly significant association. Although variants at these loci satisfied stringent statistical thresholds for significance (P o 5 Â 10 À7 ), replication in independent panels is a key validation step.
We followed up on 37 SNPs from 31 distinct loci, associated at P o 10 À5 on initial analysis of the WTCCC data set. Support for some of these markers diminished in the final WTCCC analysis after extensive data filtering 5 Among new loci with genome-wide significance in the WTCCC scan 5 , the strongest replication adjacent to a known gene was for SNPs rs13361189 and rs4958847 (P rep ¼ 6.6 Â 10 À4 and 3.1 Â 10 À4 , respectively) immediately flanking IRGM on chromosome 5q33.1. Association in the combined panels of 2,930 cases and 4,962 controls was highly significant (P comb ¼ 2.1 Â 10 À10 and 3.8 Â 10 À9 , respectively; Fig. 1 ). The long coding exon of human IRGM encodes a 20-kDa protein of 181 amino acids 6, 7 . As none of the associated SNPs are known to be functional, we resequenced this coding exon of IRGM and the four small putative downstream exons in 48 affected individuals homozygous or heterozygous for risk alleles (Supplementary Methods and Supplementary Table 5 online). We detected two new nonsynonymous sequence variants, 51G4C (E17D) and 281C4A (T94K) and an exonic synonymous SNP, 313T4C (rs10065172, L105). We then genotyped these SNPs in 769 unselected affected individuals from our study and 705 controls. Only the silent 313T4C variant was associated with Crohn's disease (P ¼ 0.008); it was in near perfect LD with SNP rs13361189 (r 2 ¼ 0.91). Sequencing of the IRGM coding region in another 100 unselected affected individuals and 100 controls did not detect additional variants. These results strongly suggest that the causal variant(s) do not change the amino acid sequence of IRGM. They may lie in regulatory sequences in LD with the associated SNPs and affect IRGM expression, or the exonic (313T4C) SNP itself might affect transcript splicing or the rate of protein translation. Analysis of IRGM expression by PCR screening of uncloned cDNA showed transcription in several tissues, including colon, small bowel, peripheral blood leukocytes and the U937 monocytic cell line (data not shown).
IRGM belongs to the p47 immunityrelated GTPase family. Its mouse homolog, LRG-47 (encoded by Irgm), critically controls intracellular pathogens by autophagy, and Irgm -/-mice show markedly increased susceptibility to Toxoplasma gondii and Listeria monocytogenes 8 . Consistent with this, IRGM induces autophagy and thereby control of intracellular Mycobacterium tuberculosis in human macrophages 7 .
Three other associations (two of which were previously unknown) reached genomewide significance in the WTCCC scan and produced strong evidence of replication (P r 0.01; Table 1 ). The strongest was SNP rs9292777 (P rep ¼ 2.9 Â 10 À7 ; P comb ¼ 3.2 Â 10 À18 ), which maps to a 1.2-Mb gene desert on chromosome 5p13.1 recently associated with Crohn's disease 9 . The most significant new association was SNP rs10883365 (P rep ¼ 0.0037, P comb ¼ 3.7 Â 10 À10 ), which maps within NKX2-3 (NK2 transcription factor related, locus 3) on chromosome 10q24.2. Nkx2-3-deficient mice develop splenic and gut-associated lymphoid tissue abnormalities with disordered segregation of T and B cells 10 . The second novel locus at rs9858542 (P rep ¼ 0.010, P comb ¼ 4.9 Â 10 À8 ) on chromosome 3p21 is a 1-Mb region of high LD that contains over 20 genes, including MST1 (macrophage stimulating 1), which encodes a protein that induces phagocytosis by resident peritoneal macrophages.
The modest evidence of replication for SNP rs2542151 (P ¼ 0.048) at the PTPN2 locus (protein tyrosine phosphatase, non-receptor type 2) on chromosome 18p11 (P comb ¼ 3.2 Â 10 À8 ) is of interest, as PTPN2 encodes a T cell protein tyrosine phosphatase, a key negative regulator of inflammation, and is also associated with type 1 diabetes 11 . Allele frequencies for rs10761659 on chromosome 10q21, strongly associated in the WTCCC scan, were similar in replication Crohn's disease cases and population controls (Supplementary Table 2 ), but association in this intergenic region was recently detected in a North American genome-wide Crohn's disease scan 12 .
Allele frequencies for most of the markers from the 25 other loci that did not achieve genome-wide significance in the WTCCC scan but had an initial P o 10 À5 converged with control frequencies in the Crohn's disease replication panel (Supplementary Table 2) . However, five of these loci provided evidence of replication (Table 1) , thus indicating that a systematic follow-up of all hits in the 10 À5 to 10 À7 range is likely to yield a number of additional susceptibility loci. Four of these loci are novel putative Crohn's disease risk loci; they include two gene deserts, both on chromosome 1q. SNP rs10801047 (P rep ¼ 4.8 Â 10 À5 , P comb ¼ 2.8 Â 10 À8 ) is located in a 1.7-Mb gene desert on chromosome 1q31.2, and rs12035082 (P rep ¼ 0.017, P comb ¼ 2.1 Â 10 À7 ) maps to chromosome 1q24 (the association signal does not extend to the nearest gene, TNFSF18). Although previous studies did not implicate IL12B (interleukin 12B) 3, 13 , modest WTCCC association at rs6887695 from this locus was replicated here (P rep ¼ 8.4 Â 10 À5 , P comb ¼ 9.2 Â 10 À6 ) and warrants follow up, particularly given its association with psoriasis 14 and the common association of IL23R with psoriasis and Crohn's disease 3, 14 . SNP rs10077785 (P rep ¼ 0.008) tags the known IBD5 locus 15 on chromosome 5q31 for which diseasecausing coding variants have yet to be confirmed, despite extensive resequencing. Finally, rs2836754 (P rep ¼ 0.012, P comb ¼ 5.5 Â 10 À7 ) maps to an intron in FLJ45139, a gene of unknown function on chromosome 21 expressed in bone marrow and colon.
We performed 'within-case' interaction analysis between known Crohn's disease susceptibility variants and replicating SNPs. For CARD15, we tested rs2066844, rs2066845 and rs2066847 independently or in combination, classifying individuals as homozygous wildtype, heterozygous or either compound heterozygote or rare-allele homozygote. We saw no significant interactions. Testing diseaseassociated variants rs11805303 in IL23R and rs10210302 in ATG16L1 also showed no interactions. Thus, these Crohn's disease risk loci seem to act independently.
We examined six sub-phenotypes of Crohn's disease and two modifiers for differential effects within cases at markers studied. We classified cases as affected or unaffected for disease site ('pure ileal' , 'pure colorectal' , 'perianal involvement') and behavior ('inflammatory' , 'stenosing' , 'penetrating') and by age of onset and smoking status (Supplementary Table 1 ). Inflammatory behavior seemed less strongly associated with rs10210302 (in ATG16L1, P ¼ 0.0003, Bonferroni P ¼ 0.010; Supplementary Table 6 online) than stenosing or penetrating behavior. We saw no further significant differential associations, although 'pure ileal' tends to associate more strongly with most replicating SNPs than does 'pure colorectal' .
This study confirms all four new Crohn's disease loci that achieved genome-wide significance in the WTCCC scan 5 and confirms the recently reported 5p13 gene desert 9 , as well as implicating four other new risk loci. These data, combined with the association in the WTCCC scan 5 and the North American study 12 of an intergenic region on chromosome 10q21, underline the value of genome-wide scanning. Taken together, the genetic evidence regarding IRGM, ATG16L1 (converging on autophagy pathways), CARD15 and IL23R strongly implicates defects in the early immune response, particularly innate immune pathways and the handling of intracellular bacteria, in the pathogenesis of Crohn's disease. Whether the latter is restricted to a single pathogen (or, more likely, to a class of subpathogenic bacteria relying on defective host innate immunity for survival) awaits further investigation.
Note: Supplementary information is available on the Nature Genetics website.
